AHA press release announcing new monitoring guidelines for patients undergoing hormonal therapies who are at high risk of cardiovascular complications.
European Society of Cardiology press release highlighting the growing need for detecting and monitoring cardiovascular side effects caused by cancer therapy.
A review of the broad range of cardiotoxicity caused by different classes of cancer therapies, existing screening options, and the growing need for cardio-oncology solutions.
A review of the impact of drug-induced cardiotoxicity on drug development, from early-phase through post-market.
Retrospective cohort study of 104,028 adults to determine when cardiovascular mortality overtakes cancer-specific mortality during survivorship.
Retrospective analysis of the incidence of cardiovascular disease in patients receiving cancer chemotherapy.
A reference list of 1318 FDA-approved drugs ranked by cardiotoxicity according to FDA labeling.
An article examining the risk, unmet needs, and future directions of cardiovascular toxicity due to radiotherapy treatments for lung cancer.
